Literature DB >> 25556571

The association of co-morbid symptoms of depression and anxiety with all-cause mortality and cardiac rehospitalization in patients with heart failure.

Abdullah S Alhurani1, Rebecca L Dekker2, Mona A Abed3, Amani Khalil4, Marwa H Al Zaghal5, Kyoung Suk Lee2, Gia Mudd-Martin2, Martha J Biddle2, Terry A Lennie2, Debra K Moser2.   

Abstract

BACKGROUND: Patients with heart failure (HF) experience multiple psychologic symptoms. Depression and anxiety are independently associated with survival. Whether co-morbid symptoms of anxiety and depression are associated with outcomes in patients with HF is unknown.
OBJECTIVE: To determine whether co-morbid symptoms of depression and anxiety are associated with all-cause mortality or rehospitalization for cardiac causes in patients with HF.
METHOD: A total of 1260 patients with HF participated in this study. Cox regression analysis was used to determine whether co-morbid symptoms of depression and anxiety independently predicted all-cause mortality and cardiac rehospitalization. Anxiety and depression were treated first as continuous-level variables, then as categorical variables using standard published cut points. Patients were then divided into 4 groups based on the presence of anxiety and depression symptoms.
RESULTS: When entered as a continuous variable, the interaction between anxiety and depression (hazard ratio = 1.02; 95% CI: 1.01-1.03; p = 0.002) was a significant predictor of all-cause mortality in patients with HF. When entered as a categorical variable, co-morbid symptoms of depression and anxiety (vs no symptoms or symptoms of anxiety or depression alone) independently predicted all-cause mortality (hazard ratio = 2.59; 95% CI: 1.49-4.49; p = 0.001). None of the psychologic variables was a predictor of cardiac rehospitalization in patients with HF whether using the continuous or categorical level of measurement.
CONCLUSION: To improve mortality outcomes in patients with HF, attention must be paid by health care providers to the assessment and management of co-morbid symptoms of depression and anxiety.
Copyright © 2015 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25556571      PMCID: PMC4285580          DOI: 10.1016/j.psym.2014.05.022

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  36 in total

1.  Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

Authors:  F Laghrissi-Thode; W R Wagner; B G Pollock; P C Johnson; M S Finkel
Journal:  Biol Psychiatry       Date:  1997-08-15       Impact factor: 13.382

Review 2.  Clinical definition and epidemiology of advanced heart failure.

Authors:  K F Adams; F Zannad
Journal:  Am Heart J       Date:  1998-06       Impact factor: 4.749

3.  Depression, adherence behavior, and coronary disease outcomes.

Authors:  R C Ziegelstein; D E Bush; J A Fauerbach
Journal:  Arch Intern Med       Date:  1998-04-13

Review 4.  Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.

Authors:  A Rozanski; J A Blumenthal; J Kaplan
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

5.  Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction.

Authors:  J Denollet; D L Brutsaert
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

6.  Psychosocial variables and hospitalization in persons with chronic heart failure.

Authors:  S J Bennett; M L Pressler; L Hays; L A Firestine; G A Huster
Journal:  Prog Cardiovasc Nurs       Date:  1997

7.  Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis.

Authors:  Jürgen Barth; Martina Schumacher; Christoph Herrmann-Lingen
Journal:  Psychosom Med       Date:  2004 Nov-Dec       Impact factor: 4.312

8.  Anxiety and vagal control of heart rate.

Authors:  L L Watkins; P Grossman; R Krishnan; A Sherwood
Journal:  Psychosom Med       Date:  1998 Jul-Aug       Impact factor: 4.312

9.  Exaggerated platelet reactivity in major depression.

Authors:  D L Musselman; A Tomer; A K Manatunga; B T Knight; M R Porter; S Kasey; U Marzec; L A Harker; C B Nemeroff
Journal:  Am J Psychiatry       Date:  1996-10       Impact factor: 18.112

10.  Association of depression with reduced heart rate variability in coronary artery disease.

Authors:  R M Carney; R D Saunders; K E Freedland; P Stein; M W Rich; A S Jaffe
Journal:  Am J Cardiol       Date:  1995-09-15       Impact factor: 2.778

View more
  13 in total

1.  Stress, cognitive appraisal, coping, and event free survival in patients with heart failure.

Authors:  Abdullah S Alhurani; Rebecca Dekker; Muayyad Ahmad; Jennifer Miller; Khalil M Yousef; Basel Abdulqader; Ibrahim Salami; Terry A Lennie; David C Randall; Debra K Moser
Journal:  Heart Lung       Date:  2018-04-04       Impact factor: 2.210

Review 2.  Depression, Anxiety, and Cognitive Impairment : Comorbid Mental Health Disorders in Heart Failure.

Authors:  Christiane E Angermann; Georg Ertl
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 3.  Depression and Anxiety in Heart Failure: A Review.

Authors:  Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman
Journal:  Harv Rev Psychiatry       Date:  2018 Jul/Aug       Impact factor: 3.732

4.  Antidepressant use in patients with heart failure.

Authors:  Kenneth E Freedland; Brian C Steinmeyer; Robert M Carney; Judith A Skala; Michael W Rich
Journal:  Gen Hosp Psychiatry       Date:  2020-04-25       Impact factor: 3.238

Review 5.  Psychological Aspects of Heart Failure.

Authors:  Debra K Moser; Cynthia Arslanian-Engoren; Martha J Biddle; Misook Lee Chung; Rebecca L Dekker; Muna H Hammash; Gia Mudd-Martin; Abdullah S Alhurani; Terry A Lennie
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

Review 6.  Autonomic Neural Circuit and Intervention for Comorbidity Anxiety and Cardiovascular Disease.

Authors:  Xuanzhao Chen; Li Xu; Zeyan Li
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

7.  Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis.

Authors:  I Sokoreli; J J G de Vries; S C Pauws; E W Steyerberg
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

8.  Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.

Authors:  Tin-Kwang Lin; Bo-Cheng Hsu; Yi-Da Li; Chi-Hsien Chen; Jiunn-Wen Lin; Chen-Yu Chien; Chia-Ying Weng
Journal:  J Am Heart Assoc       Date:  2019-06-11       Impact factor: 5.501

9.  Mindfulness, Anxiety Symptoms, and Quality of Life in Heart Failure.

Authors:  Kaitlyn Rechenberg; Lakeshia Cousin; Laura Redwine
Journal:  J Cardiovasc Nurs       Date:  2020 Jul/Aug       Impact factor: 2.468

10.  Examination of the potential association of stress with morbidity and mortality outcomes in patient with heart failure.

Authors:  Abdullah S Alhurani; Rebecca Dekker; Elizabeth Tovar; Alison Bailey; Terry A Lennie; David C Randall; Debra K Moser
Journal:  SAGE Open Med       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.